Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Limb-girdle muscular dystrophy (LGMD) is a group of rare, genetically inherited disorders characterized by progressive weakness and wasting of the muscles around the shoulders and hips (the limb-girdle). While symptoms and the age of onset can vary significantly between individuals, the condition is primarily managed through supportive care, physical therapy, and monitoring for cardiac and respiratory complications. What exactly is Limb-girdle muscular dystrophy? Limb-girdle muscular dystrophy refers to a diverse collection of more than 30 distinct genetic subtypes that primarily affect the voluntary muscles, specifically those surrounding the hips, shoulders, and upper arms/legs.
TL;DR: Limb-girdle muscular dystrophy (LGMD) is a group of rare, genetically inherited disorders characterized by progressive weakness and wasting of the muscles around the shoulders and hips (the limb-girdle). While symptoms and the age of onset can vary significantly between individuals, the condition is primarily managed through supportive care, physical therapy, and monitoring for cardiac and respiratory complications.
Limb-girdle muscular dystrophy refers to a diverse collection of more than 30 distinct genetic subtypes that primarily affect the voluntary muscles, specifically those surrounding the hips, shoulders, and upper arms/legs. Because Limb-girdle muscular dystrophy is not a single disease but a spectrum of conditions, the progression, severity, and specific muscles involved can differ greatly from person to person, even within the same family. At DiseaseMaps.org, 51 community members currently share their experiences with Limb-girdle muscular dystrophy, highlighting the broad range of clinical presentations observed in this rare disease population.
While the hallmark of Limb-girdle muscular dystrophy is skeletal muscle weakness, other systems may be involved depending on the specific genetic mutation:
Clinicians classify Limb-girdle muscular dystrophy based on the pattern of inheritance and the specific gene involved. The two primary categories are:
Diagnosis typically involves a combination of clinical physical examination, serum creatine kinase (CK) level blood tests, muscle biopsies, and definitive genetic testing to identify the specific mutation.
Because Limb-girdle muscular dystrophy encompasses many genetic variants, it can affect individuals of any gender and ethnic background. The age of onset ranges from early childhood to late adulthood; generally, symptoms that appear earlier in life tend to progress more rapidly. While prevalence data is complex due to the diversity of subtypes, it is estimated that the overall prevalence of all forms of Limb-girdle muscular dystrophy combined is approximately 1 in 14,500 to 1 in 123,000 individuals worldwide.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.